These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63. David Urdal. Interview with Asher Mullard. Nat Rev Drug Discov; 2011 Oct; 10(11):806-7. PubMed ID: 22037031 [No Abstract] [Full Text] [Related]
64. Pharma industry strategic performance: 2008-2013E. Goodman M Nat Rev Drug Discov; 2009 May; 8(5):348. PubMed ID: 19404305 [No Abstract] [Full Text] [Related]
65. A decision-support model for evaluating changes in biopharmaceutical manufacturing processes. Chhatre S; Francis R; O'Donovan K; Titchener-Hooker NJ; Newcombe AR; Keshavarz-Moore E Bioprocess Biosyst Eng; 2007 Jan; 30(1):1-11. PubMed ID: 17093973 [TBL] [Abstract][Full Text] [Related]
66. Bioreactor technology: a novel industrial tool for high-tech production of bioactive molecules and biopharmaceuticals from plant roots. Sivakumar G Biotechnol J; 2006 Dec; 1(12):1419-27. PubMed ID: 17136730 [TBL] [Abstract][Full Text] [Related]
67. Manufacturing in China. Med Device Technol; 2005 Nov; 16(9):48-9. PubMed ID: 16438451 [TBL] [Abstract][Full Text] [Related]
68. Regenerative medicine. The industry comes of age. Mason C Med Device Technol; 2007; 18(2):25-30. PubMed ID: 17494498 [TBL] [Abstract][Full Text] [Related]
70. Editorial: Biotechnology in Korea--the next generation growth engine. Lee SY Biotechnol J; 2008 May; 3(5):562-3. PubMed ID: 18481356 [No Abstract] [Full Text] [Related]
71. The farmyard drug store. Nature; 2006 Sep; 443(7107):16-7. PubMed ID: 16957702 [No Abstract] [Full Text] [Related]
72. Channeling chip power: Tissue chips are being put to the test by industry. Willyard C Nat Med; 2017 Feb; 23(2):138-140. PubMed ID: 28170380 [No Abstract] [Full Text] [Related]